Generics 27

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Leucovorin calcium manufacturers

27 products found

Filters

27 products found

leucovorin calcium

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Manufacturer #17782
Over 40 years ago, it was founded in North America. The company has long been a leader in the generic product manufacturing industry. It has earned a name for itself in the production of branded and over-the-counter private label items. Customers are actively and attentively listened to by the company. They anticipate the evolution of new markets and are ready to adapt to new medical needs.

Manufacturer usually replies in 8 days

leucovorin calcium

Injection, lyophilized 50 mg/5 ml , 100 mg/10 ml , 300 mg/30 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA, WHO, Saudi Arabia
Registered in
Thailand
Manufacturer #8924
This European pharmaceutical company specializes in manufacturing a range of products including prescription medications, over-the-counter drugs, and medical devices. They possess a strong research focus with a GLP accredited research unit driving innovation in the sector. The company holds GMP certifications and boasts an extensive portfolio protected by patents. Key therapy areas include oncology and anti-infective treatments, with principal dosage forms including vials and tablets. They cater to markets across the EU and other regulated regions, emphasizing quality control through rigorous testing and a dedicated packaging facility for specialized products like Cephalosporins and Oncology medications.

Manufacturer usually replies in 9 days

leucovorin calcium

Injection 50 mg , 100 mg , 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283
This company is a leading manufacturer of anti-cancer medications, specializing in a wide range of oncology drugs including those for solid tumors, hematology, and supportive care. They boast a portfolio of over 100 products with a focus on cost-effectiveness through in-house API development and manufacturing. The company's commitment to innovation is evident in their New Drug Delivery System (NDDS) formulations which aim to improve patient compliance and reduce medication waste. Their strong R&D pipeline promises further advancements in the oncology field. They hold WHO-GMP certifications for their API plant, enabling both domestic and international market reach. Key therapy areas include AML, Renal Cell Carcinoma, Gastro-Intestinal tumors, Pancreatic Neuroendocrine Tumors, Thyroid cancer, and Prostate cancer.

Manufacturer usually replies in 4 days

Want to see all 27 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible